ArticleTherapeutics and clinical risk management2026
Exploring the Effects of Prone Position Ventilation Combined with Drug on Clinical Outcomes in Neonates with ARDS: A Single-Center Retrospective Cohort Study.
Article in Therapeutics and clinical risk management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the association of prone position ventilation combined with intravenous ambroxol versus conventional supine ventilation on clinical outcomes in neonates with acute respiratory distress syndrome (ARDS). Methods: Neonates with ARDS admitted to the Neonatal Intensive Care Unit (NICU) of the Second Affiliated Hospital of Fujian Medical University between January 2023 and December 2024 were included. A total of 80 neonates were allocated into two groups (n=40 each) based on a temporal shift in clinical practice: an Observation Group receiving prone positioning (target >16 hours/day) plus intravenous ambroxol (7.5 mg/kg twice daily for 5 days), and a Control Group receiving supine ventilation alone. Both groups received standard lung-protective ventilation and co-interventions per protocol. The primary outcome was ventilator-free days (VFDs) to day 28. Results: The primary outcome, VFDs, was significantly higher in the observation group (median [IQR]: 18 [15-21] days) than in the control group (14 [10-17] days; P=0.003). The observation group also had a shorter duration of mechanical ventilation (mean difference: 2.04 days; 95% CI: 1.55 to 2.53; P<0.001) and a shorter hospital length of stay (mean difference: 6.55 days; 95% CI: 5.61 to 7.49; P<0.001). Physiological parameters improved more favorably in the observation group, with a significant Group × Time interaction for the Oxygenation Index (P<0.001) and a lower peak inspiratory pressure at 72 hours (adjusted mean difference: -1.95 cmH Conclusion: In this cohort, the combination therapy was associated with significantly improved respiratory outcomes and a lower complication rate in neonates with ARDS, suggesting it may be a beneficial adjunctive strategy. These findings warrant validation in a prospective randomized trial.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.